EUVIMEDEUVIMED entdecken
Crossref

A Novel Mechanism of Chlorogenic Acid in Cardioprotection: Blocking NLRP3 Inflammasome via Ca 2+ /CaMKIIα Signaling in Sepsis‐Induced Cardiomyopathy

Huadong Meng iD, Kegong Chen, Zhonghua Lu, Weili Yu, Xinyi Hu, Hanqing Xu, Shusheng Zhou, Song Peng, Xiaohui Guo, Yun Sun

The FASEB Journal · 2025

DOI: 10.1096/fj.202502567rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Huadong Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Sepsis, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Anhui natural science reserach key project, China Postdoctoral Foundation Project | Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation), Postdoctoral Research Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis‐induced cardiomyopathy (SICM) is a severe complication of sepsis, characterized by myocardial inflammation, oxidative stress, and cardiac dysfunction. Chlorogenic acid (CGA), a natural polyphenol with known anti‐inflammatory and antioxidant properties, is abundant in many traditional medicinal plants used for cardiovascular and inflammatory disorders. However, its cardioprotective effects in SICM and the underlying mechanisms remain unclear. An in vivo cecal ligation and puncture (CLP) model was used to induce SICM in rats, followed by CGA treatment. Cardiac function and myocardial injury markers were assessed, while NLRP3 inflammasome activation and CaMKIIα involvement were investigated using molecular docking, gene overexpression, and site‐directed mutagenesis. H9c2 cardiomyocytes were treated with lipopolysaccharide (LPS) and hypoxia/reoxygenation (H/R) to establish an in vitro SICM model. Mitochondrial function and pyroptosis were evaluated using oxygen consumption rate (OCR), extracellular acidification rate (ECAR), scanning electron microscopy (SEM), and key protein expression analysis. CGA improved cardiac function, reduced myocardial injury markers, and alleviated inflammation and fibrosis in SICM rats. CGA (25 μM) improved H9c2 cell viability in LPS + H/R‐induced SICM by reducing LDH, CK‐MB, and cTnT levels and suppressing inflammation, oxidative stress, and pyroptosis. It preserved mitochondrial function and cristae structure. Molecular docking and functional studies confirmed CGA binds to CaMKIIα and NLRP3, inhibiting inflammasome activation via the Ca 2+ /CaMKIIα pathway. Mutation of the GLU60 binding site abolished CGA's protective effects both in vitro and in vivo. CGA ameliorates SICM by suppressing NLRP3 inflammasome activation and pyroptosis through the Ca 2+ /CaMKIIα pathway. These findings offer new insights into CGA's cardioprotective effects and highlight its potential as a therapeutic agent for SICM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCalcium-Calmodulin-Dependent Protein Kinase Type 2SepsisInflammasomesChlorogenic AcidCardiomyopathiesCalciumCardiotonic AgentsAnimalsRatsMaleRats, Sprague-DawleySignal TransductionMyocytes, CardiacMolecular Docking SimulationPyroptosis

Stichwörter der Autor:innen

CaMKIIαNLRP3 inflammasomechlorogenic acid (CGA)pyroptosissepsis‐induced cardiomyopathy

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinCalcium-Calmodulin-Dependent Protein Kinase Type 2InflammasomesChlorogenic AcidNlrp3 protein, ratCalciumCardiotonic Agents

Autor:innen und Institutionen

  • The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Intensive Care Unit (ICU), The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, Anhui, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of General Practice, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Department of Emergency Medical Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Huadong Meng

Förderung

  • Anhui natural science reserach key project
  • China Postdoctoral Foundation Project | Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation)
  • Postdoctoral Research Foundation of China

Zitieren

APA

Meng, H., Chen, K., Lu, Z., Yu, W., Hu, X., Xu, H., Zhou, S., Peng, S., Guo, X., & Sun, Y. (2025). A Novel Mechanism of Chlorogenic Acid in Cardioprotection: Blocking NLRP3 Inflammasome via Ca 2+ /CaMKIIα Signaling in Sepsis‐Induced Cardiomyopathy. The FASEB Journal. https://doi.org/10.1096/fj.202502567rr

Vancouver

Meng H, Chen K, Lu Z, Yu W, Hu X, Xu H, et al. A Novel Mechanism of Chlorogenic Acid in Cardioprotection: Blocking NLRP3 Inflammasome via Ca 2+ /CaMKIIα Signaling in Sepsis‐Induced Cardiomyopathy. The FASEB Journal. 2025. doi:10.1096/fj.202502567rr

BibTeX
@article{Meng2025,
  author = {Meng, Huadong and Chen, Kegong and Lu, Zhonghua and Yu, Weili and Hu, Xinyi and Xu, Hanqing and Zhou, Shusheng and Peng, Song and Guo, Xiaohui and Sun, Yun},
  title = {A Novel Mechanism of Chlorogenic Acid in Cardioprotection: Blocking NLRP3 Inflammasome via Ca 2+ /CaMKIIα Signaling in Sepsis‐Induced Cardiomyopathy},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502567rr}
}
Kostenlos starten →